A small placebo-controlled study found that treatment with GH injections in ME/CFS patients over 12 months was beneficial: a few of the patients were even able to resume work after long periods of sick leave (94). The gene discussed is GH1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.